Matthew E. Pipkin

4.9k citations
43 papers · 3.5k · 3 hit papers · h-index 20

Impact in

  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • IL-33, ST2, and ILC Pathways
  • Oncology top 2%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immune Cell Function and Interaction 25
    • T-cell and B-cell Immunology 20
    • Immunotherapy and Immune Responses 12
    • CRISPR and Genetic Engineering 4

Matthew E. Pipkin

41 papers receiving 3.5k citations

Matthew E. Pipkin's Hit Papers

Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours 2017 · 464 citations
4640+5+10Years since publication200400600

Peers

Matthew E. Pipkin
Comparison fields: 5 of 101
  • Immunology 2.4k
  • Oncology 1.0k
  • Virology 78
  • Cancer Research 226
  • Molecular Biology 909
Replace Benedict Seddon with:
Benedict Seddon United Kingdom
Stephan Gasser Singapore
Philip G. Ashton‐Rickardt United States
Pinaki P. Banerjee United States
Arnold Han United States
Viktor Steimle Switzerland
Annick Mühlethaler‐Mottet Switzerland
Satoru Kumaki Japan
Maki Nakayama United States
Paul Rogers United States
Matthew E. Pipkin relative to Benedict Seddon United Kingdom Benedict Seddon's profile →
Citations per field
00.5×1.5×2.0×
Benedict Seddon · 1×
Citations per year

Countries citing papers authored by Matthew E. Pipkin

Since Specialization
Citations

This map shows the geographic impact of Matthew E. Pipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Pipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Pipkin more than expected).

Fields of papers citing papers by Matthew E. Pipkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew E. Pipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Pipkin. The network helps show where Matthew E. Pipkin may publish in the future.

Co-authors

The 25 scholars most cited alongside Matthew E. Pipkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Matthew E. Pipkin Line = papers co-authored together Matthew E. Pipkin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T Cells
Hit paper breakdown →
2010623
2
The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
Hit paper breakdown →
2015556
3
Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours
Hit paper breakdown →
2017464
4 2009382
5 2007187
6 2017182
7 2018126
8 2003102
9 2020100
10 201486
11 200982
12 201380
13 202165
14 202062
15 201057
16 200946
17 200734
18 202033
19 202121
20 200621

About Matthew E. Pipkin

Matthew E. Pipkin is a scholar working on Immunology, Molecular Biology, Oncology, Virology and Public Health, Environmental and Occupational Health, having authored 43 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (25 papers), T-cell and B-cell Immunology (20 papers), Immunotherapy and Immune Responses (12 papers), CAR-T cell therapy research (6 papers), HIV Research and Treatment (5 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers) and CRISPR and Genetic Engineering (4 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (1.0k citations), Virology (78 citations), Cancer Research (226 citations) and Molecular Biology (909 citations). Matthew E. Pipkin has collaborated with scholars based in United States, Brazil and South Korea. Frequent co-authors include Anjana Rao, Mathias G. Lichtenheld, Fernando Cruz‐Guilloty, Shane Crotty, Jilian A. Sacks, Michael J. Bevan, Ananda W. Goldrath, Bingfei Yu, J. Justin Milner and Adam J. Getzler. Their work appears in journals such as The Journal of Immunology, Immunity, Nucleic Acids Research, Proceedings of the National Academy of Sciences and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact